TC-99M HMDP (HYDROXYMETHYLENE DIPHOSPHONATE) - A RADIOPHARMACEUTICAL FOR SKELETAL AND ACUTE MYOCARDIAL INFARCT IMAGING .1. SYNTHESIS AND DISTRIBUTION IN ANIMALS
- 1 January 1980
- journal article
- research article
- Vol. 21 (10) , 961-966
Abstract
Technetium-99m hydroxymethylene diphosphonate (99mTc HMDP) is a new diphosphonate skeletal imaging agent. Animal studies show that 99mTc HMDP has a higher uptake on bone and a more rapid clearance from the blood than any of the 3 Tc-labeled bone imaging agents in current use: 99mTc methylene diphosphonate (MDP), 99mTc (1-hydroxyethylidene) diphosphonate (HEDP), and 99mTc pyrophosphate (PPi). Based on these animal studies, 99mTc HMDP is a highly promising candidate for skeletal imaging.This publication has 7 references indexed in Scilit:
- GENTISIC ACID - A NEW STABILIZER FOR LOW TIN SKELETAL IMAGING AGENTS - CONCISE COMMUNICATION1980
- Structure of disodium dihydrogen 1-hydroxyethylidenediphosphonate tetrahydrate: a bone growth regulatorActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1979
- CLINICAL COMPARISON OF TC-99M HEDP AND TC-99M MDP IN THE DETECTION OF BONE METASTASES - CONCISE COMMUNICATION1979
- CLINICAL COMPARISON OF TECHNETIUM-99M DIPHOSPHONATE AND PYROPHOSPHATE IN BONE SCINTIGRAPHY - CONCISE COMMUNICATION1978
- USE OF WHOLE-BODY RETENTION OF TC-99M DIPHOSPHONATE IN DIAGNOSIS OF METABOLIC BONE-DISEASE1978
- PHARMACOKINETICS OF TECHNETIUM-99M DIPHOSPHONATE1977
- INVITRO STABILIZATION OF A LOW TIN BONE-IMAGING AGENT (SN-HEDP-TC-99M) BY ASCORBIC-ACID1976